These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2148193)

  • 1. Efficacy and tolerance of doxazosin: a review.
    Brown MJ
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():34-8. PubMed ID: 2148193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T; Westlie L; Daae LN
    J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P; Fagard R; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T; Westlie L; Daae L
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].
    Daae LN; Kierulf P; Brusletto B; Westheim A; Holme I; Syvertsen JO
    Tidsskr Nor Laegeforen; 1991 Apr; 111(9):1102-5. PubMed ID: 1827216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doxazosin for the treatment of arterial hypertension].
    Mozzato MG; Semplicini A; Serena L; Valle R; Casolino P; Buzzaccarini F; Rubino N; Giusto M; Pessina AC
    Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and lipid lowering effects of terazosin.
    Rosenthal J
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():85-9; discussion 90-1. PubMed ID: 2575179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral antihypertensive agents on blood lipid levels.
    Leren P
    Clin Ther; 1986; 8(3):309-19. PubMed ID: 2872961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
    Ames RP; Kiyasu JY
    J Clin Pharmacol; 1989 Feb; 29(2):123-7. PubMed ID: 2565917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the efficacy and safety of doxazosin in the treatment of hypertension associated with renal insufficiency.
    Anderton JL; Notghi A
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():52-7. PubMed ID: 2148196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC
    Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
    Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR;
    Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparative study of doxazosin and prazosin in the treatment of essential hypertension.
    Fukiyama K; Omae T; Iimura O; Yoshinaga K; Yagi S; Inagaki Y; Ishii M; Kaneko Y; Yamada K; Ijichi H
    Am Heart J; 1991 Jan; 121(1 Pt 2):317-22. PubMed ID: 1824654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of doxazosin on blood pressure and renal haemodynamics of hypertensive patients with renal failure.
    Bailey RR; Nairn PL; Walker RJ
    N Z Med J; 1986 Dec; 99(815):942-5. PubMed ID: 2949169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.